Article citationsMore>>

Ye, Z., Wang, Y., Colunga-Lozano, L.E., Prasad, M., Tangamornsuksan, W., Rochwerg, B., et al. (2020) Efficacy and Safety of Corticosteroids in COVID-19 Based on Evidence for COVID-19, Other Coronavirus Infections, Influenza, Community-Acquired Pneumonia, and Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis. Canadian Medical Association Journal, 192, E756-E767.
https://doi.org/10.1503/cmaj.200645

has been cited by the following article:

• TITLE: Diabetes during COVID-19 Pneumonia in a 16-Year-Old Girl: A Case Report in Cameroon

  AUTHORS: Ritha Mbono Betoko, Charlotte Eposse, Suzanne Sap, Betsy Bate, Gaelle Ntsoli, Hassanatou Iyawa, Calixte Ida Penda

  KEYWORDS: Covid-19, Diabetes, Adolescents

  JOURNAL NAME: Open Journal of Pediatrics, Vol.14 No.4, July 8, 2024

  ABSTRACT: Background: Diabetes is a known risk factor for susceptibility and severity of COVID-19 infection. It may also be a complication of COVID-19. Many hypotheses have been proposed to explain this condition. It may be due to the effect of SARS-CoV-2 on β cells or drug-related side effects. In children, there is a paucity of data on the burden of this complication. Objective: We aimed to report a case of secondary diabetes during COVID-19 in a pediatric unit. Case Presentation: A 16-year-old girl presented with severe respiratory distress. She was treated for COVID-19 infection with antibiotics and corticosteroids. On day 6 of treatment, she developed polyuria and polydipsia. A random blood glucose test showed hyperglycaemia. The diagnosis of secondary diabetes was maintained. Conclusion: Covid-19 infection can be complicated by diabetes in children. It is essential to monitor blood glucose levels regularly.